TickerFacts.

Eledon Pharmaceuticals, Inc. (ELDN): Capital Expenditures

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2016-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

Older than the company's other figures. The latest Capital Expenditures is for the year ended 2016-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$9.0K
Year ended 2016-12-31
$565.0K2012-12-31: $8.0K2013-12-31: $23.0K2014-12-31: $25.0K2015-12-31: $565.0K2016-12-31: $9.0K$9.0K
2012-12-31 Capital Expenditures (USD) 2016-12-31
Period endedCapital ExpendituresChange YoYSource filing
2016-12-31$9.0Kn/c2018-04-02, From 2016-01-01
2015-12-31$565.0Kn/m2017-03-03, From 2015-01-01
2014-12-31$25.0K+8.7%2017-03-03, From 2014-01-01
2013-12-31$23.0K+187.5%2016-03-10, From 2013-01-01
2012-12-31$8.0Kn/a2015-03-26, From 2012-01-01